Prothrombin 20210A and Oral Contraceptive Use as Risk Factors for Cerebral Venous Thrombosis

By  

Cerebrovascular Diseases, Vol. 19, Iss. 1, 2005-01 ,pp. : 49-52

Karger

Access to resources Recommend Favorite

The Prothrombin Gene G20210A Mutation and the Platelet Glycoprotein IIIa Polymorphism Pl A2 in Patients with Central Retinal Vein Occlusion - The Stroke Prevention in Young Women Study

By Larsson J.   Hillarp A.  

Thrombosis Research, Vol. 96, Iss. 4, 1999-11 ,pp. : 323-327

Elsevier

Access to resources Recommend Favorite

Prothrombin Activity and Concentration in Healthy Subjects with and without the Prothrombin G20210A Mutation

By von Ahsen N.   Lewczuk P.   Schutz E.   Oellerich M.   Ehrenreich H.  

Thrombosis Research, Vol. 99, Iss. 6, 2000-09 ,pp. : 549-556

Elsevier

Access to resources Recommend Favorite

17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities

By Maier Polyana S.   Mattiello Simone S.   Lages Luiza   Spritzer Poli M.  

Gynecological Endocrinology, Vol. 28, Iss. 8, 2012-08 ,pp. : 606-610

Informa Healthcare

Access to resources Recommend Favorite

Long-term oral contraceptive treatment, metabolic syndrome and measures of cardiovascular risk in pre-menopausal women: National Health and Nutrition Examination Survey 1999-2004

By Hurwitz Barry   Henry Nicole   Goldberg Ronald  

Gynecological Endocrinology, Vol. 25, Iss. 7, 2009-07 ,pp. : 441-449

Informa Healthcare

Access to resources Recommend Favorite